section name header
Index
30
35
38
45
59
Acute Coronary Syndrome and Myocardial Infarction - Related Resources
Adult
Adverse effects
Anticoagulants for Acute Ischaemic Stroke
Anticoagulants for Intermittent Claudication
Anticoagulants for Preventing Recurrence after Acute Ischaemic Stroke
Anticoagulants
Anticoagulant therapy
Anticoagulation for the Long Term Treatment of Venous Thromboembolism in Patients with Cancer
Anticoagulation
Antiplatelet and Anticoagulation for Patients with Prosthetic Heart Valves
Antithrombotic Agents in Primary Health Care - Related Resources
Aspirin
Atrial Fibrillation
Bone Density
Cardiology
Cerebrovascular Accident
Changes of Bone Density after Exposure to Oral Anticoagulants
Chronic kidney disease
Clinical pharmacology
Clinical pharmacology
Clopidogrel
Cochrane review
Computerized Advice on Drug Dosage to Improve Prescribing Practice
Creatinine
Death
Direct Oral Anticoagulants
Direct Oral Anticoagulants Versus Vitamin K Antangonists in Non-Valvular Atrial Fibrillation
Direct Oral Anticoagulants Versus Warfarin Among Atrial Fibrillation Patients with Chronic Kidney Disease
Disease
Drug Therapy
Electrical Cardioversion
Embolism
Endocrinology
Evidence summary
Exposure
Follow-up
Gynaecology
Heart
Hemorrhage
Indications for and Implementation of Anticoagulant Therapy in Atrial Fibrillation - Related Resources
Internal medicine
Internal medicine
Kidney
Liver
Lower Limb Ischaemia - Related Resources
Lumbar spine
Meta-analysis
Mortality
Myocardial infarction
Neck
Neurology
Neurology
Noac Versus Warfarin Postpci in Atrial Fibrillation
Oral Anticoagulants Vs Antiplatelet Therapy for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Stroke or TIA
Oral anticoagulant
Oral Anticoagulation for Prolonging Survival in Patients with Cancer
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism
Osteoporosis - Related Resources
Osteoporosis
Patients
Pharmacology
Platelet Aggregation Inhibitors
Prevention
Primary Prevention
Primary Prophylaxis for Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy
Prophylaxis
Risk Factors
Risk
Sensitivity
Spine
Stroke
Systematic review
Thrombosis
Tranexamic Acid in People on Anticoagulants Undergoing Minor Oral Surgery or Dental Extractions
Vitamin K for Improved Anticoagulation Control in Patients Receiving Warfarin
Vitamin K
Warfarin for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Cerebral Ischaemia
Warfarin or Antiplatelet Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Warfarin Therapy - Related Resources
Warfarin